
FibroGen founder and CEO Thomas Neff dies unexpectedly as lead drug nears commercial threshold
FibroGen founder and CEO Thomas Neff died “unexpectedly” over the weekend, says the biotech company.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,500+ biopharma pros reading Endpoints daily — and it's free.